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The  observation  has  been  made  frequently  (1-5)  that  monkeys 
actively immunized with different preparations of the virus of polio- 
myelitis  while  developing humoral  antibodies,  often  do  not  resist 
either intracerebral or intranasal inoculations of the virus.  In this 
paper we shall present our experiences with the nasal instillation in 
monkeys which have passed through clinically perceptible attacks of 
experimental poliomyelitis and the correlation of the effects produced 
with humoral antibodies present as quantitatively ascertained.  The 
study has practical significance in determining whether a certain con- 
centration of antiviral bodies in vaccinated monkeys has the same 
value as regards protection to infection as it has in convalescents. 
The  question  of  reinfection  in  convalescent  monkeys  has  been 
studied by F1exner  (6) in relation especiaUy to second attacks of the 
disease in children.  Contrary to accepted views, he has found that 
reinfection takes  place  in  nasally  instilled monkeys,  and  that  the 
second attack may sometimes be induced by the same although ap- 
parently oftener by a  foreign strain of virus; and he has also made 
tests for the presence of humoral antibodies to both kinds of strains 
in the reinfected animals (personal communication). 
EXPEI~NTAL 
Reaction of Convalescent Monkeys to Nasal Instillation of Virus.--As 
early as 1910, Flexner (7)  and later others  (8 a, 9)  showed that mon- 
keys convalescent from experimental poliomyelitis are, with only rare 
exceptions, resistant  to intracerebral  inoculation of the same strain 
of virus. 
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Monkeys inoculated with the Rockefeller Institute strain of mixed virus (M. 
V.) which was used in this study rarely recover after the development of paralysis; 
the  collection of a  suitable  number of convalescents for this  investigation  was 
therefore no easy task (cf. Flexner (7,  10)).  Of the nine  monkeys studied, five 
were originally infected with virus by way of the nose and four by intracerebral 
injection.  The intranasal  test for susceptibility consisted of two instillations of 
virus, 48 hours apart.  A  10 per cent suspension in saline was used of a mixture 
of glycerolated cords from at least four monkeys, paralyzed after nasal infection, 
and  1 cc.  was instilled  in each nostril.  At least  three or four normal monkeys 
received the same virus suspension by the same route, whenever any of the con- 
valescents  were being tested.  During  this  study  thirty  control monkeys were 
used and all developed poliomyelitis. 
Of the  nine  convalescent  monkeys given  one  or more  series  of in- 
stillations  at  monthly  intervals,  six  resisted the intranasal  tests and 
three  died in a  peculiar  manner. 
Flexner (I1) has shown that the bringing of virus into contact with the nasal 
membrane is never an indifferent process in monkeys and that both normal and 
convalescent animals respond to its presence with changes in the cerebrospinal 
fluid consisting of mononudear pleocytosis and even of globulin; and this response 
takes place largely independently of the appearance of obvious clinical symptoms 
of disease.  Certain  monkeys are  highly resistant  to  the  nasal  instillation  of 
virus, but these exceptional animals still react with the changes in the cerebro- 
spinal fluid,  from which Flexuer concluded that "the refractory state,  therefore, 
resides apparently in the nerve cells, the principal seat of usual virus attack--not 
in the nervous tissues  as a  whole."  The resistance of the animals in our series 
was measured by the complete absence of fever or other signs of disease as con- 
trasted with the uniform occurrence of paralysis among the control monkeys in 
each experiment. 
The histories of the  three  animals which succumbed in an  unusual 
manner  are  as follows: 
Macacus rhesus 1-82, the first of the series to succumb, was completely paralyzed 
after the first nasal infection.  It recovered some function, however, and 3 months 
later  was again submitted  to nasal instillation  of virus.  4  days after  the first 
instillation  and within less than 48 hours after the second,  it was found dead; 
the only signs before death appeared  to be increased weakness and subnormal 
temperature (99.2 ° and 96.7°F.) on the 2nd and 3rd days.  The cause of death was 
not investigated in this case, because the rapid course did not suggest poliomyelitis. 
Subsequently, however, two additional monkeys (Nos. 3-07 and 3-26)  died in 
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sis of only the lower extremities  following the original intracerebral  inoculation, 1 
but remained  otherwise well and active with normal temperature (about 102°F.) 
for 1 month, when it was given virus intranasally.  The  temperature dropped 
to 100.2°F. the next day, and to 100°F. on the 2nd day, when it appeared sick 
and seemed to breathe with difficulty; it was given still another nasal instillation 
of  virus  and  was  found  dead  the  following  morning.  Necropsy revealed  no 
pathological  changes  in the lungs  or viscera.  The olfactory bulbs were  tested 
for virus,  but  contained  none,  and  microscopic examination  of sections  of the 
central  nervous  system revealed  only old  poliomyelitis  lesions.  Monkey 3-07 
exhibited  complete paralysis  of the left arm and some weakness of the other ex- 
tremities  as a  result  of the original intracerebral  inoculation  but was otherwise 
well and active with normal temperature  (about 102.4°F.) for 5 weeks, when it 
was submitted to the same test as monkey 3-26.  For the next 2 days it exhibited 
no change  either  in temperature or in physical  condition.  On the 3rd  day, or 
24 hours after  the  second  nasal  instillation  of virus,  its  temperature  dropped 
to  100.7°F.; it appeared ill and had difficulty in breathing.  On the 4th day it 
was almost prostrate, temperature 97.6°F., and respiration  exceptionally  difficult 
and of irregular  rhythm.  It was anesthetized  and sacrificed at this stage; the 
lungs  and  viscera  showed  no evidence  of disease,  the  central  nervous  system 
showed  no gross  changes,  and  microscopically  there  was  evidence  of only old 
poliomyelitis  lesions.  The olfactory bulbs,  thalamic region,  pons and medulla 
were tested for the presence of poliomyelitis virus but none was found.  It may 
be pointed out that another convalescent  monkey, No. 4-2, was given the same 
virus suspension  simultaneously  with monkeys 3-07 and 3-26, but remained  en- 
tirely well, and that three normal controls  developed  typical poliomyelitis  after 
the usual course of fever and within the usual time.  None of the other convales- 
cent monkeys tested subsequently  by the same procedure exhibited any abnormal 
signs. 
From the evidence presented here one cannot attribute the deaths 
of these three convalescent monkeys to a  second attack of poliomye- 
litis.  Although there are reports of certain reactions in convalescent 
monkeys  (such  as  a  rapid  rise  in  temperature  after  intracerebral 
inoculation  (12)  or  rapid  death  after  intrasplenic  injection  of  virus 
(13)  which  have  been  interpreted  as  allergic  or  anaphylactic mani- 
festations,  one cannot be  at all certain that  such phenomena played 
a  part  in  the  cases  just  described.  At the  same  time  it  is  difficult 
to dismiss these three deaths as merely coincidental. 
Neutralizing  Antibodies in Convalescent Monkeys.--All the convales- 
cent monkeys were bled at monthly intervals after the onset of paraly- 
l All such operations  were made with the aid of deep ether anesthesia. 742  ANTIBODIES  AND  RESISTANCE  TO  POLIOMYELITIS 
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sis and prior  to reinoculation,  in order to determine whether or not 
they possessed demonstrable antibodies at the time they were tested 
for resistance to reinfection  (Table I). 
The neutralization test was performed in the same manner as that previously 
used by Olitsky and  Cox (2) for demonstrating antibody in the serum of vac- 
cinated monkeys, whose resistance to infection is now being compared with that 
of the convalescents.  In brief, 0.2 cc. of a Berkefeld N filtrate of a 5 per cent 
suspension of poliomyelitis cords in saline solution was mixed with 0.8 cc. of the 
serum, incubated  2 hours at 37°C., and overnight  in the refrigerator,  and the 
whole mixture injectedintracerebrally  in a  monkey.  The  amount  of virus in 
this mixture represented approximately twenty minimal infective doses. 
It should be noted that none of the sera obtained from five monkeys 
had  any  demonstrable  antibodies  4  to  5  weeks  after  the  onset  of 
paralysis;  at  2  months  the  sera of only two of six  monkeys tested 
failed to neutralize,  while at 3 months these two also exhibited anti- 
viral bodies.  Many of the neutralization  tests were repeated several 
times with the same results; hence it is clear that the development of 
antiviral  bodies in convalescent monkeys is generally quite slow and 
at times may require  as long as 3 months  to become demonstrable. 
Reports of the presence of antibody as early as 36 hours after paralysis 
(8b)  should,  therefore,  be regarded  either  as  exceptional  or  as  the 
result possibly of misinterpretation  of a  single test.  Leake  (14)  re- 
ported the absence of neutralizing  antibodies in  a  monkey 1 month 
after the onset of poliomyelitis, and Aycock and Kramer  (15)  found 
no  antibody  in  two  convalescent  sera  obtained  4  to  6  weeks after 
paralysis,  although  at  6  months  after  the  disease  the  sera  of these 
animals  neutralized  the virus. 
Antibody in the Preparalytic Stage.--In a report published after the 
completion of the above experiments, Jungeblut  (9) stated that anti- 
bodies appear  first during  the  preparalytic  stage,  disappear  rapidly 
during  the onset of paralysis,  and  then  reappear  slowly during  con- 
valescence.  This conclusion is based on the observation that of the 
sera of nine monkeys in the preparalytic stage, four completely neu- 
tralized 0.2  cc. of a  10 per cent virus suspension,  one partially neu- 
tralized (as reflected by prolongation of the incubation period for more 
than 14 days), and the remainder failed to neutralize.  When paralysis 
ensued,  however,  the  monkeys which  previously had  demonstrable ALBERT B.  SABIN AND  PETER  K.  OLITSKY  745 
antibodies now showed none.  In an attempt to repeat this finding, 
the sera of six monkeys in the preparalytic stage were tested against 
0.2  cc.  of 5  per  cent  virus filtrate  (Berkefeld N),  but  none of them 
neutralized. 
TABLE II 
Titration of Antiviral  Substance in Sets of Monkeys  Which Resisted or 
Succumbed to Nasal Infection witk Poliomyelitis  Virus 
Amount of 
serum added 
Source  of  serum  to  0.2  cc.  of  5%  Result  of  test 
Berkcfeld N 
filtratc* 
From  three convalescent monkeys 
which resisted repeated attempts 
at reinfection by way of nose 
From three vaccinated  monkeys  which 
succumbed to  nasal instillation of 
virus 
From one similarly vaccinated mon- 
key which resisted nasal infection 
on four attempts at monthly inter- 
vals but succumbed to an intracere- 
bral injection of 0.5 cc. of 5% virus 
suspension 
Normal monkey sera 
6G. 
0.8 
0.4 
0.I 
0.025 
0.8 
0.4 
0.I 
0.025 
0,8 
0.I 
0.025 
0.8 
o.st 
Neutralization 
Partial  neu  tralization?--paralysis 
after 17 days, incubation 
Neutralization 
No neutralization 
Neutralization 
Partial  neutmUzation?~paralysis 
after 15 days' incubation 
No neutralization 
Neutralization 
C~ 
No neutralization 
* Total mixture made up to 1 cc. with saline,  when necessary, and after in- 
cubation injected intracerebrally in a  monkey. 
t Only 0.1  cc. of a  Berkefeld  N  filtrate of  5 per cent  virus  suspension  was 
used in this mixture. 
Correlation between  Antibody  and  Susceptibility  to  Reinfection.--It 
is evident from the results shown in Table I that convalescent monkeys 
are resistant to reinfection at a time when their sera contain no demon- 
strable antibody.  By the use of the same test,  antiviral bodies were 
readily detected in the serum of vaccinated monkeys which proved to 746  ANTIBODIES  AND  RESISTANCE  TO  POLIOMYELITIS 
be fully susceptible to the nasal instillation of poliomyelitis virus (2). 
It is clear, therefore, that the difference in resistance between convales- 
cent and vaccinated monkeys is not directly related to the content 
of antiviral bodies.  In order to  study further the possible quanti- 
tative relationship between the humoral antibodies and resistance to 
nasal infection, the sera of three convalescent monkeys, bled  after 
the development of demonstrable antibodies, were pooled and titrated 
simultaneously with  the  pooled  sera  of  three  vaccinated monkeys 
which failed to resist infection.  The serum of another monkey (vac- 
cinated at the same time and in the same manner as the other three) 
which resisted four different intranasal tests at monthly intervals but 
succumbed to an intracerebral inoculation of 0.5 cc. of a  5 per cent 
virus suspension was similarly titrated.  Decreasing amounts of the 
various sera were added to a constant amount of virus, i.e.,  0.2 cc. of 
a  Berkefeld N  filtrate of a  5  per cent pooled cord suspension, the 
amount employed in all the other neutralization tests.  The results, 
shown in Table II, indicate no appreciable quantitative difference in 
serum antibody in monkeys which resisted infection and in vaccinated 
monkeys which succumbed to the same intranasal test dose of polio- 
myelitis virus. 
DISCUSSION 
In view of the recently accumulated evidence which indicated that 
the majority of monkeys, treated with preparations of active virus, 
are not rendered resistant to nasal instillations of poliomyelitis virus 
in spite of the fact that they develop readily demonstrable serum anti- 
viral bodies (I, 2, 3, 5), it was desirable to examine by similar methods 
the resistance and  serum antibodies of monkeys recovering from a 
distinct paralytic attack of the experimental disease. 
In recent years investigators who found vaccinated monkeys with 
serum antibodies and without resistance to intracerebral or intranasal 
infection with  poliomyelitis virus postulated  a  certain  "tissue  im- 
munity" as distinct from humoral immunity (I).  It was not clear, 
however, to what extent variations in the quantitative level of anti- 
bodies in the serum could account for the difference in susceptibility or 
resistance to infection.  Thus it may have been supposed that conva- 
lescent monkeys and those of the vaccinated ones which resisted infec- 
tion might have had a  larger amount of serum antibodies. ALBERT  B.  SABIN  AND  PETER  K.  OLITSKY  747 
In  the  present  investigation,  nine  convalescent  monkeys were 
tested for susceptibility to infection with poliomyelitis virus by way 
of the nose.  Three of these monkeys succumbed with unusual signs, 
but careful postmortem study eliminated a second attack of polio- 
myelitis as the cause of death; the remaining six successfully resisted 
repeated instillations of virus which in each case produced poliomyeli- 
tis in all the control monkeys.  Of particular interest was the observa- 
tion that convalescent monkeys were resistant to reinfection before 
antiviral bodies were demonstrable in their serum, and that the sera 
of all the monkeys tested several times 4  to 5 weeks after paralysis 
contained no demonstrable antibody; all monkeys, however, finally 
developed antibodies--some of  them  at  2  months and  others  not 
until 3 months after the onset of paralysis.  It should be pointed out 
that by the use of the same test, vaccinated monkeys have been shown 
to contain readily demonstrable serum antibody at 5 to 6 weeks after 
the first inoculation without, however, exhibiting any resistance to 
the same amount of virus instilled intranasaUy (2).  Itwasfurthermore 
demonstrated that the serum of convalescent monkeys, when anti- 
body finally appeared in it, was no more potent than that of the sus- 
ceptible,  vaccinated  monkeys.  It  is  interesting  to compare these 
results with some of those recently reported by Jungeblut (9).  His 
studies differed from these in that the virus was injected intracere- 
brally.  He  showed  that  of  twenty-three  convalescent  monkeys 
studied at different times after the onset of paralysis, all resisted re- 
inoculation with large doses of virus (no peculiar deaths of the type 
described here were reported) and this resistance was apparent  long 
before the appearance of antibodies in the serum.  It appears, there- 
fore, that the resistance of convalescent monkeys to reinfection with 
the same strain of virus by either the intracerebral or intranasal routes 
cannot  be  correlated  with  the  demonstrable presence  of  antiviral 
bodies in  the  blood.  In order  to  avoid misleading generalizations 
from this observation, it should be recalled that different viruses may 
act differently in the same host, and that even the same virus may 
vary in this respect in two distinct hosts.  Thus, the virus of equine 
encephalomyelitis readily  and  rapidly induces serum antibodies in 
Macacus rhesus  monkeys, most of which do not become resistant to 
intracerebral  inoculation of the virus  (16), while in  the guinea pig 
even completely inactivated, formolized vaccines give rise to an ex- 7481  ANTIBODIES AND RESISTANCE TO POLIOMYELITIS 
traordinary  resistance  to  intracerebral  inoculation  (1000  M.I.D. or 
more)  with very little or no antibody in the serum  (17). 
CONCLUSIONS 
1.  Monkeys convalescent from a  paralytic  attack of poliomyelitis 
develop humoral  antibodies  slowly; in  the  present  series  their  first 
appearance in most was at 2 months and in some not until 3 months 
after the attack. 
2.  Convalescent  monkeys  display  resistance  to  reinfection  with 
the  same  strain  by  the  nasal  route  long  before antibodies  become 
demonstrable in their serum, in this respect differing from many vac- 
cinated monkeys whose serum neutralizes the virus, while they remain 
susceptible to nasal infection. 
3.  When antibodies appear in the serum of resistant  convalescent 
monkeys,  they are  not  quantitatively  greater  than  in  the  serum  of 
vaccinated  monkeys which  succumb to infection.  As regards resist- 
ance  to  infection,  humoral  antibodies,  therefore,  do  not  have  the 
same  significance  in  vaccinated  as  in  convalescent  poliomyelitis 
monkeys. 
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